Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42613 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-05-29 | 2020-07-09 | 116165 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2020-10-30 | 2021-01-21 | 127607 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141125 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Resolved | 2023-07-18 | 2023-08-18 | 198960 |
TEVA-GEMFIBROZIL | 600MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-13 | 229233 |
TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2019-07-02 | 2020-07-23 | 88164 |
TEVA-GLICLAZIDE | 80MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167244 |
TEVA-GLYBURIDE | 2.5MG | TABLET | Actual shortage | 2024-01-18 | 2024-02-15 | 216460 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2017-03-13 | 2017-04-25 | 1841 |
TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2017-03-17 | 2017-04-03 | 3127 |
TEVA-HALOPERIDOL | 0.5MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43132 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2018-03-16 | 2018-07-30 | 43135 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2019-11-28 | 2020-01-24 | 99929 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120479 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2020-08-20 | 2020-11-07 | 122688 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125470 |
TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2021-04-01 | 2021-06-10 | 136755 |
TEVA-HALOPERIDOL | 5MG | TABLET | Resolved | 2021-04-29 | 2021-06-10 | 138317 |
TEVA-HALOPERIDOL | 1MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140375 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |